Evolva Holding SA · ISIN: CH0021218067 · EQS - adhoc news

Change in Evolva Holding SA's shareholder structure

 PRESS RELEASE | AD HOC ANNOUNCEMENT PURSUANT TO ART. 53 LR   Change in Evolva's shareholder structure Reinach, Switzerland, 30 December 2024 — Evolva Holding SA (SIX: EVE) ("Evolva") was informed by its largest shareholder Nice & Green SA, Nyon, that it had sold all its Evolva shares to an unnamed third party. Nice & Green SA, Nyon, Evolva’s largest shareholder with a latest reported shareholding of 19.344%, informed Evolva that it had sold all its Evolva shares to a third party. Th...

SIX:EVE Price indication powered by TradingView

About the publication

Corporate Insights - Short Sales, Director's Dealings, Sentiment Indicators - THE info hub for the informed investor

Smart tools for smart investors can be found in our Tools section

Corporate News Evolva Holding SA

In this overview you can view company news in the chronological order of publication. The source information comes from EQS News, the leading European news distributor. The most recent news item is listed first.
Back to Corporate News Overview
This might be interesting for you as well
Analyst Ratings (0)
Directors Dealings (0)
Short Selling (DE) (0)
Short Selling (UK) (0)
30 December 2024 07:00AM
Change in Evolva Holding SA's shareholder structure
CH0021218067
 PRESS RELEASE | AD HOC ANNOUNCEMENT PURSUANT TO ART. 53 LR   Change in Evolva's shareholder structure Reinach, Switzerland, 30 December 2024 — Evolva Holding SA (SIX: EVE) ("Evolva") was informed by its largest shareholder Nice & Green SA, Nyon, that it had sold all its Evolva shares to an unnamed third party. Nice & Green SA, Nyon, Ev...
Evolva Holding SA
About the publication
29 October 2024 07:00AM
Evolva Holding AG publishes half-year report 2024 and IFRS annual report 2023
CH0021218067
PRESS RELEASE | AD HOC ANNOUNCEMENT PURSUANT TO ART. 53 LR   Evolva publishes half-year report 2024 and IFRS annual report 2023 Reinach, Switzerland, 29 October 2024 — Evolva Holding SA (SIX: EVE) today published the consolidated IFRS annual financial statements 2023 and the half-year report 2024 in accordance with applicable stock exchange regul...
Evolva Holding SA
About the publication
15 July 2024 07:00AM
Approval of temporary exemption from certain conditions for maintaining listing pursuant to art. 7 Listing Rules; IFRS financial statements for 2023 and half-year 2024 to be publish
CH0021218067
PRESS RELEASE | AD HOC ANNOUNCEMENT PURSUANT TO ART. 53 LR   Approval of temporary exemption from certain conditions for maintaining listing pursuant to art. 7 Listing Rules; IFRS financial statements for 2023 and half-year 2024 to be published by 31 October 2024 Reinach, Switzerland, 15 July 2024 — On 12 July 2024, Evolva Holding SA (SIX: EVE) (...
Evolva Holding SA
About the publication
12 April 2024 07:10PM
Shareholders of Evolva Holding SA in liquidation approve BoD proposals at AGM; revocation of liquidation and delisting also approved whereas introduction of opting-out was rejected
CH0021218067
Evolva Holding SA / Key word(s): AGMEGM Shareholders of Evolva Holding SA in liquidation approve BoD proposals at AGM; revocation of liquidation and delisting also approved whereas introduction of opting-out was rejected 12.04.2024 / 19:10 CET/CEST PRESS RELEASE | AD HOC ANNOUNCEMENT PURSUANT TO ART. 53 LR   Shareholde...
Evolva Holding SA
About the publication
12 April 2024 04:56PM
Shareholders of Evolva Holding SA in liquidation approve BoD proposals at AGM; revocation of liquidation and delisting also approved whereas introduction of opting-out was rejected
CH0021218067
PRESS RELEASE | AD HOC ANNOUNCEMENT PURSUANT TO ART. 53 LR   Shareholders of Evolva Holding SA in liquidation approve proposals put forward by the Board of Directors at Annual General Meeting; of the three agenda items put forward by Nice & Green, revocation of the liquidation and the delisting were also approved whereas introduction of opting...
Evolva Holding SA
About the publication
26 March 2024 12:17AM
Approval of temporary exemption from certain conditions for maintaining listing pursuant to art. 7 Listing Rules
CH0021218067
PRESS RELEASE | AD HOC ANNOUNCEMENT PURSUANT TO ART. 53 LR   Reinach, Switzerland, 26 March 2024 — On 25 March 2024, Evolva Holding SA in liquidation (SIX: EVE) received from SIX Exchange Regulation AG ("SER") a temporary exemption from certain conditions for maintaining listing pursuant to art. 7 Listing Rules. Evolva had applied for these exempt...
Evolva Holding SA
About the publication
22 March 2024 07:01AM
Evolva Holding in liquidation SA publishes liquidation interim financial statements and agenda for 2024 annual general meeting; reports positive purchase price adjustment of CHF 1,929,000 under SPA; g
CH0021218067
PRESS RELEASE | AD HOC ANNOUNCEMENT PURSUANT TO ART. 53 LREvolva Holding SA in liquidation publishes liquidation interim financial statements and agenda for 2024 annual general meeting; reports positive purchase price adjustment of CHF 1,929,000 under SPA; gives update on expected liquidation dividend Reinach, Switzerland, 22 March 2024 — Evolva H...
Evolva Holding SA
About the publication
07 March 2024 07:00AM
Nice & Green requests 3 agenda items be included in AGM agenda
CH0021218067
PRESS RELEASE | AD HOC ANNOUNCEMENT PURSUANT TO ART. 53 LR   Shareholder Nice & Green SA requests 3 agenda items to be included in the agenda of the upcoming Annual General Meeting; shareholder Pegasus Global Opportunity Fund Ltd crosses 10% threshold Reinach, Switzerland, 7 March 2024 — Evolva Holding SA in liquidation (SIX: EVE) (“Evolva”) ...
Evolva Holding SA
About the publication
28 December 2023 05:45PM
Evolva and Lallemand close the sale of Evolva AG to Danstar Ferment AG on 28 December 2023
CH0021218067
Evolva Holding SA / Key word(s): Takeover Evolva and Lallemand close the sale of Evolva AG to Danstar Ferment AG on 28 December 2023 28.12.2023 / 17:45 CET/CEST PRESS RELEASE   Evolva and Lallemand close the sale of Evolva AG to Danstar Ferment AG on 28 December 2023 Reinach, Switzerland, 28 December 2023 — Following ...
Evolva Holding SA
About the publication
21 December 2023 05:45PM
Shareholders approve the sale of Evolva AG to Lallemand Inc. Swiss subsidiary at extraordinary general meeting
CH0021218067
Evolva Holding SA / Key word(s): AGMEGM Shareholders approve the sale of Evolva AG to Lallemand Inc. Swiss subsidiary at extraordinary general meeting 21.12.2023 / 17:45 CET/CEST PRESS RELEASE   Shareholders approve the sale of Evolva AG to Lallemand Inc. Swiss subsidiary at extraordinary general meeting Reinach, 21 D...
Evolva Holding SA
About the publication
30 November 2023 07:00AM
Evolva convenes extraordinary general meeting (EGM) for 21 December 2023 to approve the sale of Evolva AG to Lallemand Inc.
CH0021218067
PRESS RELEASE | AD HOC ANNOUNCEMENT PURSUANT TO ART. 53 LR Evolva convenes extraordinary general meeting (EGM) for 21 December 2023 to approve the sale of Evolva AG to Lallemand Inc. The Board of Directors proposes the following to the shareholders: Approval of the sale of Evolva AG to Lallemand Inc. subsidiary to secure the future of Evolva’s o...
Evolva Holding SA
About the publication
21 November 2023 07:00AM
Evolva enters into an agreement to sell its operations to Lallemand, securing the best possible outcome for the company and its stakeholders
CH0021218067
PRESS RELEASE | AD HOC ANNOUNCEMENT PURSUANT TO ART. 53 LR   Evolva enters into an agreement to sell its operations to Lallemand, securing the best possible outcome for the company and its stakeholders Evolva and Danstar Ferment AG, a Swiss affiliate of Lallemand Inc., have signed a share purchase agreement regarding the sale and purchase, respec...
Evolva Holding SA
About the publication
14 November 2023 07:00AM
Evolva and Breko broaden partnership by signing agreement for the exclusive distribution of Veri-teTM Resveratrol in Germany, Austria, Thailand and Vietnam
CH0021218067
Evolva Holding SA / Key word(s): Agreement Evolva and Breko broaden partnership by signing agreement for the exclusive distribution of Veri-teTM Resveratrol in Germany, Austria, Thailand and Vietnam 14.11.2023 / 07:00 CET/CEST PRESS RELEASE   Evolva and Breko broaden partnership by signing agreement for the exclusive d...
Evolva Holding SA
About the publication
28 September 2023 07:00AM
Evolva and LEHVOSS sign agreement for distribution of Veri-teTM Resveratrol in over a dozen European countries
CH0021218067
PRESS RELEASE | AD HOC ANNOUNCEMENT PURSUANT TO ART. 53 LREvolva and LEHVOSS sign agreement for distribution of Veri-teTM Resveratrol in over a dozen European countries Reinach, 28 September 2023 — Evolva (SIX: EVE), a pioneer in the field of natural molecules and industrial biotech, and LEHVOSS UK Ltd. (“LEHVOSS”), a leading European distributor ...
Evolva Holding SA
About the publication
13 September 2023 07:00AM
Evolva and Nice & Green agree on improvements to financing agreement
CH0021218067
PRESS RELEASE | AD HOC ANNOUNCEMENT PURSUANT TO ART. 53 LR Evolva and Nice & Green agree on improvements to financing agreement Reinach, 13 September 2023 — Evolva (SIX: EVE), a pioneer in the field of natural molecules and industrial biotech, agreed with its financing partner Nice & Green SA on changes to its financing arrangement, with ...
Evolva Holding SA
About the publication
06 September 2023 07:00AM
Evolva receives approval for Veri-teTM Resveratrol in Thailand
CH0021218067
Evolva Holding SA / Key word(s): Regulatory Approval Evolva receives approval for Veri-teTM Resveratrol in Thailand 06.09.2023 / 07:00 CET/CEST PRESS RELEASE  Evolva receives approval for Veri-teTM Resveratrol in Thailand Reinach, 06 September 2023 – Evolva (SIX: EVE), a pioneer in the field of natural mole...
Evolva Holding SA
About the publication
24 August 2023 08:00PM
Evolva shareholders approve increase of the conditional capital and upper limit of capital band at extraordinary general meeting of 24 August 2023
CH0021218067
Evolva Holding SA / Key word(s): AGMEGM Evolva shareholders approve increase of the conditional capital and upper limit of capital band at extraordinary general meeting of 24 August 2023 24.08.2023 / 20:00 CET/CEST PRESS RELEASE   Evolva shareholders approve increase of the conditional capital and upper limi...
Evolva Holding SA
About the publication
24 August 2023 07:00AM
Evolva with good business momentum and significant progress in profitability in 1H 2023, despite major financing challenges
CH0021218067
PRESS RELEASE | AD HOC ANNOUNCEMENT PURSUANT TO ART. 53 LREvolva with good business momentum and significant progress in profitability in 1H 2023, despite major financing challenges Reinach, 24 August 2023 — Evolva (SIX: EVE), a pioneer in the field of natural molecules and industrial biotech, reported sales of CHF 4.5 million for the first half o...
Evolva Holding SA
About the publication
28 July 2023 07:00AM
Evolva convenes extraordinary general meeting (EGM) for 24 August 2023 to secure financing until end of the year
CH0021218067
PRESS RELEASE | AD HOC ANNOUNCEMENT PURSUANT TO ART. 53 LREvolva convenes extraordinary general meeting (EGM) for 24 August 2023 to secure financing until end of the year Board of Directors proposes the following to the shareholders: Increase of the conditional capital for the purpose of Nice & Green financing Increase in the upper limit of ...
Evolva Holding SA
About the publication
28 July 2023 07:00AM
Evolva convenes extraordinary general meeting (EGM) for 24 August 2023 to secure financing until end of the year
CH0021218067
PRESS RELEASE | AD HOC ANNOUNCEMENT PURSUANT TO ART. 53 LREvolva convenes extraordinary general meeting (EGM) for 24 August 2023 to secure financing until end of the year Board of Directors proposes the following to the shareholders: Increase of the conditional capital for the purpose of Nice & Green financing Increase in the upper limit of ...
Evolva Holding SA
About the publication
25 July 2023 07:00AM
Evolva receives approval for Veri-teTM Resveratrol in Taiwan
CH0021218067
Evolva Holding SA / Key word(s): Regulatory Approval Evolva receives approval for Veri-teTM Resveratrol in Taiwan 25.07.2023 / 07:00 CET/CEST PRESS RELEASE  Evolva receives approval for Veri-teTM Resveratrol in Taiwan Reinach, 25 July 2023 – Evolva (SIX: EVE) a pioneer in the field of natural molecules and i...
Evolva Holding SA
About the publication
25 July 2023 07:00AM
Evolva receives approval for Veri-teTM Resveratrol in Taiwan
CH0021218067
Evolva Holding SA / Key word(s): Regulatory Approval Evolva receives approval for Veri-teTM Resveratrol in Taiwan 25.07.2023 / 07:00 CET/CEST PRESS RELEASE  Evolva receives approval for Veri-teTM Resveratrol in Taiwan Reinach, 25 July 2023 – Evolva (SIX: EVE) a pioneer in the field of natural molecules and i...
Evolva Holding SA
About the publication
26 June 2023 07:00AM
Evolva signs agreement with Nice & Green to secure financing at least until the end of 2023, continues to pursue strategic alternatives
CH0021218067
PRESS RELEASE | AD HOC ANNOUNCEMENT PURSUANT TO ART. 53 LR   Evolva signs agreement with Nice & Green to secure financing at least until the end of 2023, continues to pursue strategic alternatives Reinach, 26 June 2023 — Evolva (SIX: EVE), a pioneer in the field of natural molecules and industrial biotech, and its financing partner Nice &...
Evolva Holding SA
About the publication
26 June 2023 07:00AM
Evolva signs agreement with Nice & Green to secure financing at least until the end of 2023, continues to pursue strategic alternatives
CH0021218067
PRESS RELEASE | AD HOC ANNOUNCEMENT PURSUANT TO ART. 53 LR   Evolva signs agreement with Nice & Green to secure financing at least until the end of 2023, continues to pursue strategic alternatives Reinach, 26 June 2023 — Evolva (SIX: EVE), a pioneer in the field of natural molecules and industrial biotech, and its financing partner Nice &...
Evolva Holding SA
About the publication
14 June 2023 07:00AM
Evolva informs about renegotiation of financing arrangement, initiates review of strategic alternatives and revokes guidance
CH0021218067
PRESS RELEASE | AD HOC ANNOUNCEMENT PURSUANT TO ART. 53 LR   Evolva informs about renegotiation of financing arrangement, initiates review of strategic alternatives and revokes guidance Reinach, 14 June 2023 — Evolva (SIX: EVE), a pioneer in the field of natural molecules and industrial biotech, is in discussions with its financing partner Nice &...
Evolva Holding SA
About the publication
14 June 2023 07:00AM
Evolva informs about renegotiation of financing arrangement, initiates review of strategic alternatives and revokes guidance
CH0021218067
PRESS RELEASE | AD HOC ANNOUNCEMENT PURSUANT TO ART. 53 LR   Evolva informs about renegotiation of financing arrangement, initiates review of strategic alternatives and revokes guidance Reinach, 14 June 2023 — Evolva (SIX: EVE), a pioneer in the field of natural molecules and industrial biotech, is in discussions with its financing partner Nice &...
Evolva Holding SA
About the publication
05 May 2023 07:00AM
Evolva signs multi-year agreement with leading CMO partner to enable supply of Vanillin to global F&F customer of around CHF 35 million until 2026
CH0021218067
PRESS RELEASE | AD HOC ANNOUNCEMENT PURSUANT TO ART. 53 LR   Evolva signs multi-year agreement with leading CMO partner to enable supply of Vanillin to global F&F customer of around CHF 35 million until 2026 Reinach, 5 May 2023 — Evolva (SIX: EVE), a pioneer in the field of natural molecules and industrial biotech, has reached a major milesto...
Evolva Holding SA
About the publication
05 May 2023 07:00AM
Evolva signs multi-year agreement with leading CMO partner to enable supply of Vanillin to global F&F customer of around CHF 35 million until 2026
CH0021218067
PRESS RELEASE | AD HOC ANNOUNCEMENT PURSUANT TO ART. 53 LR   Evolva signs multi-year agreement with leading CMO partner to enable supply of Vanillin to global F&F customer of around CHF 35 million until 2026 Reinach, 5 May 2023 — Evolva (SIX: EVE), a pioneer in the field of natural molecules and industrial biotech, has reached a major milesto...
Evolva Holding SA
About the publication
24 April 2023 07:00AM
Evolva publishes timeline of the Reverse Stock Split
CH0021218067
Evolva Holding SA / Key word(s): AGMEGM Evolva publishes timeline of the Reverse Stock Split 24.04.2023 / 07:00 CET/CEST   Reinach, 24 April 2023 — Evolva (SIX: EVE), a pioneer in the field of natural molecules and industrial biotech, today communicates on the timeline of the reverse stock split of 250:1 which was approved by ...
Evolva Holding SA
About the publication
24 April 2023 07:00AM
Evolva publishes timeline of the Reverse Stock Split
CH0021218067
Evolva Holding SA / Key word(s): AGMEGM Evolva publishes timeline of the Reverse Stock Split 24.04.2023 / 07:00 CET/CEST   Reinach, 24 April 2023 — Evolva (SIX: EVE), a pioneer in the field of natural molecules and industrial biotech, today communicates on the timeline of the reverse stock split of 250:1 which was approved by ...
Evolva Holding SA
About the publication
18 April 2023 05:30PM
Evolva shareholders approve all motions proposed by the Board at today’s Annual General Meeting
CH0021218067
Evolva Holding SA / Key word(s): AGMEGM Evolva shareholders approve all motions proposed by the Board at today’s Annual General Meeting 18.04.2023 / 17:30 CET/CEST Press Release (PDF) The shareholders approved, among others: The Reverse stock split of 250:1, followed by a reduction of the par value of the shares to CHF 1.00 I...
Evolva Holding SA
About the publication
18 April 2023 05:30PM
Evolva shareholders approve all motions proposed by the Board at today’s Annual General Meeting
CH0021218067
Evolva Holding SA / Key word(s): AGMEGM Evolva shareholders approve all motions proposed by the Board at today’s Annual General Meeting 18.04.2023 / 17:30 CET/CEST Press Release (PDF) The shareholders approved, among others: The Reverse stock split of 250:1, followed by a reduction of the par value of the shares to CHF 1.00 I...
Evolva Holding SA
About the publication
28 March 2023 07:00AM
Evolva goes Responsible Care at in-cosmetics 2023
CH0021218067
Evolva Holding SA / Key word(s): Product Launch Evolva goes Responsible Care at in-cosmetics 2023 28.03.2023 / 07:00 CET/CEST Press Release (PDF) PRESS RELEASE Evolva is globally launching an exclusive line of nature-based high-purity ingredients and bio-functionals for the personal care industry, produced in a sustainable mann...
Evolva Holding SA
About the publication
28 March 2023 07:00AM
Evolva goes Responsible Care at in-cosmetics 2023
CH0021218067
Evolva Holding SA / Key word(s): Product Launch Evolva goes Responsible Care at in-cosmetics 2023 28.03.2023 / 07:00 CET/CEST Press Release (PDF) PRESS RELEASE Evolva is globally launching an exclusive line of nature-based high-purity ingredients and bio-functionals for the personal care industry, produced in a sustainable mann...
Evolva Holding SA
About the publication
24 March 2023 07:00AM
Evolva publishes agenda for 2023 Annual General Meeting
CH0021218067
Ad Hoc Announcement (PDF) PRESS RELEASE | AD HOC ANNOUNCEMENT PURSUANT TO ART. 53 LR Board of Directors proposes, among others, the following to the shareholders: Reverse stock split of 250:1, followed by a reduction of the nominal value of the shares to CHF 1.00 Introduction of a capital band of up to 20% of current share capital to give the B...
Evolva Holding SA
About the publication
24 March 2023 07:00AM
Evolva publishes agenda for 2023 Annual General Meeting
CH0021218067
Ad Hoc Announcement (PDF) PRESS RELEASE | AD HOC ANNOUNCEMENT PURSUANT TO ART. 53 LR Board of Directors proposes, among others, the following to the shareholders: Reverse stock split of 250:1, followed by a reduction of the nominal value of the shares to CHF 1.00 Introduction of a capital band of up to 20% of current share capital to give the B...
Evolva Holding SA
About the publication
09 March 2023 07:00AM
Evolva delivers accelerated revenue growth of 57% in 2022 and substantially improved profitability profile
CH0021218067
Ad Hoc Announcement (PDF) PRESS RELEASE | AD HOC ANNOUNCEMENT PURSUANT TO ART. 53 LR Reinach, 9 March 2023 — Evolva (SIX: EVE), a pioneer in the field of natural molecules and industrial biotech, delivered a strong performance during 2022, fully meeting its targets. Total revenue increased by 57% (prior year +40%) to CHF 15.5 million, while produ...
Evolva Holding SA
About the publication
09 March 2023 07:00AM
Evolva delivers accelerated revenue growth of 57% in 2022 and substantially improved profitability profile
CH0021218067
Ad Hoc Announcement (PDF) PRESS RELEASE | AD HOC ANNOUNCEMENT PURSUANT TO ART. 53 LR Reinach, 9 March 2023 — Evolva (SIX: EVE), a pioneer in the field of natural molecules and industrial biotech, delivered a strong performance during 2022, fully meeting its targets. Total revenue increased by 57% (prior year +40%) to CHF 15.5 million, while produ...
Evolva Holding SA
About the publication
06 March 2023 07:20AM
Evolva partners with Grace Breeding to replace chemical fertilizers with nature-based alternative
CH0021218067
Ad Hoc Announcement (PDF) PRESS RELEASE | AD HOC ANNOUNCEMENT PURSUANT TO ART. 53 LR   By leveraging Evolva’s precision-fermentation technology, Grace Breeding’s Nitrogen Fixation solution has demonstrated the desired impact on yield and overall crop resilience   Reinach, Switzerland and Rehovot, Israel, 6 March 2023 — Evolva (SIX: EVE), a pio...
Evolva Holding SA
About the publication
06 March 2023 07:20AM
Evolva partners with Grace Breeding to replace chemical fertilizers with nature-based alternative
CH0021218067
Ad Hoc Announcement (PDF) PRESS RELEASE | AD HOC ANNOUNCEMENT PURSUANT TO ART. 53 LR   By leveraging Evolva’s precision-fermentation technology, Grace Breeding’s Nitrogen Fixation solution has demonstrated the desired impact on yield and overall crop resilience   Reinach, Switzerland and Rehovot, Israel, 6 March 2023 — Evolva (SIX: EVE), a pio...
Evolva Holding SA
About the publication
11 January 2023 07:00AM
Evolva delivers strong results with 57% revenue growth and increasing margins
CH0021218067
Total revenues grew by 57% in 2022 to CHF 15.5 million Gross contribution margin increased to around 21% in H2 2022 – after 10.9% in H1 For the full year 2022, gross contribution margin amounted to around 16% For 2023, Evolva expects revenues of over CHF 20 million and a gross contribution margin of above 20% Reinach, 11 January 2023 – Evolva (...
Evolva Holding SA
About the publication
14 December 2022 07:00AM
Evolva launches its Natural Nootkatone
CH0021218067
Evolva Holding SA / Key word(s): Market launch Evolva launches its Natural Nootkatone 14.12.2022 / 07:00 CET/CEST Reinach, 14 December 2022 – Evolva (SIX: EVE) a pioneer in the field of natural molecules and industrial biotech, is lauching “Natural Nootkatone by Evolva”, a natural ingredient at the highest purity level now meeti...
Evolva Holding SA
About the publication
14 December 2022 07:00AM
Evolva launches its Natural Nootkatone
CH0021218067
Evolva Holding SA / Key word(s): Market launch Evolva launches its Natural Nootkatone 14.12.2022 / 07:00 CET/CEST Reinach, 14 December 2022 – Evolva (SIX: EVE) a pioneer in the field of natural molecules and industrial biotech, is lauching “Natural Nootkatone by Evolva”, a natural ingredient at the highest purity level now meeti...
Evolva Holding SA
About the publication
12 December 2022 06:45AM
Evolva statement to SER communication
CH0021218067
Evolva Holding SA / Key word(s): Statement Evolva statement to SER communication 12.12.2022 / 06:45 CET/CEST Sanctions Commission of SIX Group followed Evolva’s main arguments Addressed deficiencies are related to incomplete disclosures and technical mistakes related to the goodwill impairment tests in the financial reporting ...
Evolva Holding SA
About the publication
12 December 2022 06:45AM
Evolva statement to SER communication
CH0021218067
Evolva Holding SA / Key word(s): Statement Evolva statement to SER communication 12.12.2022 / 06:45 CET/CEST Sanctions Commission of SIX Group followed Evolva’s main arguments Addressed deficiencies are related to incomplete disclosures and technical mistakes related to the goodwill impairment tests in the financial reporting ...
Evolva Holding SA
About the publication
29 November 2022 07:00AM
Update on activities to boost Resveratrol
CH0021218067
Evolva Holding SA / Key word(s): Product Launch Evolva: Update on activities to boost Resveratrol 29.11.2022 / 07:00 CET/CEST Reinach, 29 November 2022 – Evolva (SIX: EVE), a pioneer in the field of natural molecules and industrial biotech, today provides an update on the ongoing activities to boost the commercial performance of Resver...
Evolva Holding SA
About the publication
29 November 2022 07:00AM
Update on activities to boost Resveratrol
CH0021218067
Evolva Holding SA / Key word(s): Product Launch Evolva: Update on activities to boost Resveratrol 29.11.2022 / 07:00 CET/CEST Reinach, 29 November 2022 – Evolva (SIX: EVE), a pioneer in the field of natural molecules and industrial biotech, today provides an update on the ongoing activities to boost the commercial performance of Resver...
Evolva Holding SA
About the publication
10 November 2022 07:01AM
Evolva receives approval for Veri-teTM Resveratrol for animal health in Brazil
CH0021218067
Evolva Holding SA / Key word(s): Regulatory Approval Evolva receives approval for Veri-teTM Resveratrol for animal health in Brazil 10.11.2022 / 07:01 CET/CEST Reinach, 10 November 2022 – Evolva (SIX: EVE) a pioneer in the field of natural molecules and industrial biotech, has received approval for its Veri-teTM  Resveratrol fr...
Evolva Holding SA
About the publication
More Evolva Holding SA related information
Type Total Last Made by Go to
Corporate Research 0 - - Corporate Research
Directors Dealings 0 - - DD
Short Seller (DE) 0 - - SSR (DE)
Short Seller (UK) 0 - - SSR (UK)
Disclaimer:

The combination of information with graphic elements makes an important contribution to visual orientation and navigation through complex factual topics. Essential content features can be perceived, grasped and contextually processed much faster. 
The figurative marks, logos and other graphic and textual elements used on this website are for illustrative purposes only. All rights to the aforementioned elements are held by their respective owners. They are used without the intention of copyright infringement or intellectual property infringement.

If you believe that copyrights or intellectual property have been infringed by the choice of illustration, please contact us immediately to clarify the issue.

v.07062023 EN